Member Info for Oldapache

So, we see the constant attack on our directors.

What are these idiots blaming them for? The only blame is that these idiots bought at a price that they now believe was too high and are not now prepared to be patient to see their Investment realise it's potential.

So who's to blame for that?

Lack of due diligence, which incorporates all the aspects of understanding the directors, the products, the market sector, it's peers, timeframes, funding, etc,etc.

Reading the constant t drivel would put potential Investors off so the idiots are complicit with / are the shortest and attacking our share price.

Nobody pressed the buy button, you did.

Just saying for balance, if you can't stand the heat.......................

Cos it. = cash cow.

Mourning all Tilsiests, ( see what I did there ) @ DCR, 12 years, your having a laaf, we are due serious up rate in short order due to the 5 yes 5 NDAs concluding together with a large number of our product portfolio coming on stream at various stages within the next months/year.

Just saying.

Stick in there peeps, this is a cash cos it you allow it to play out.

Vbw

What’s Accustem?

No such product

Ha, ha.

Trade

Bobsson,

You still have time to complete the docs to be able to trace of you want to.

Vbw

Marco, and they understand pharma far greater than us.

Vbw

Of the 534 hospitalised last week, 20% had received both jabs!

No my maths are fine as you have based yours on 250m, but it was rns’d 206m currently.

Denny11,

Hi, sorry for late response but just been sunning in the garden.

250,000,000 divided by $12.500,000 as per TP link earlier.

I fink??????

vbw

HiSporty66,
Wow, I am quite pleased with 25pps.

What are your expectations?

bestest,

TradePheonix,

Thanx for the link.

By my simple understanding, looking like 25p p/s. Anyone confirm or reject?

vbw

Yep, set my buy order @ 34p.

roughly equates to 3.20 GBP P/S for any newbies thinking of Investing.

vbw

Ridiculous, doh.

Fatgreek1,

Fully agree based on your point added to the fact that the drop is standard practice pre buy-out notwithstanding all pharma's are taking a beating due to anticipated "inflation figures" and "covid variants" having an anticipated lower immunity efficasy than original figures, were all "lumped together for some rediculous reason.

vbw

Excellent post, thanx.

" Investors" need to take back the BB to reality of our potential Billion/s $ company and not let the moaners put off potential new Investors.

vbw

you can't see what's happening here you should'nt be Investing in any markets.

This is a multi billion $ company, within a multi billion /s market/s with multi billion products.

Now go play a monopoly board as that's the closest you will get to being wealthy.

You just could'nt make it up, the pathetic moaners.

Get a life!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Trading 13% up equiv 88p since opening.

Exchange rate is nowhere near the reason for the differential.

vbw

Denny11,

I would normally agree with you but the Bods appear to have changed their view to listing on NAS only, however, they could again change their view and list on both exchanges, possibly for legal reasons otherwise why did they not come out and say it in one syllable?

I still can't get over the fact that it should have be quite specific within an RNS!

All smoke and mirrors with Accustem, but why? Beggars belief.

Anyways, time will tell.

bestest